慢性粒细胞白血病发病机制及治疗进展(5)
[19] Kantarjian HM，Giles F，Gattermann N，et al. Nilotinib(formerly AMN107)，a highly selective BCR—ABL tyrosine kinase inhibitor，is effective in patients with Philadelphia chromosome—positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance[J]. Blood，2007，110：3540—3546.[20] Bixby D ......
您现在查看是摘要页，全文长 2927 字符。